Neuron specific enolase, carcinoembryonic antigen and lactate dehydrogenase as indicators of disease activity in small cell lung cancer.

[1]  E. Cooper,et al.  Serum neuron-specific enolase in children's cancer. , 1987, British Journal of Cancer.

[2]  E. Newlands,et al.  Neuron-specific enolase (NSE) as a tumour marker and comparative evaluation with carcinoembryonic antigen (CEA) in small-cell lung cancer , 1987, Medical oncology and tumor pharmacotherapy.

[3]  R. Elashoff,et al.  Evaluation of three biochemical markers for serially monitoring the therapy of small-cell lung cancer. , 1987, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[4]  M. Peake,et al.  Neuron-specific enolase as a guide to the treatment of small cell lung cancer. , 1987, European journal of cancer & clinical oncology.

[5]  J. Bergh,et al.  Serum deoxythymidine kinase in small cell carcinoma of the lung: Relation to clinical features, prognosis, and other biochemical markers , 1986, Cancer.

[6]  M. Hansen,et al.  Tumor markers in patients with lung cancer. , 1986, Chest.

[7]  J. Sculier,et al.  Carcinoembryonic antigen: a useful prognostic marker in small-cell lung cancer. , 1985, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[8]  M. Muers,et al.  Evaluation of a radioimmunoassay for neuron specific enolase in small cell lung cancer. , 1985, British Journal of Cancer.

[9]  J. Bergh,et al.  Neurone specific enolase: a useful diagnostic serum marker for small cell carcinoma of the lung. , 1985, Thorax.

[10]  R. Makuch,et al.  Elevated serum creatine kinase BB levels in patients with small cell lung cancer. , 1984, Cancer research.

[11]  J. Hainsworth,et al.  Potential utility of serum neuron-specific enolase levels in small cell carcinoma of the lung. , 1984, Cancer research.

[12]  R. Ruddon,et al.  Multiple sequential biomarkers in monitoring patients with carcinoma of the lung. , 1984, Cancer treatment reports.

[13]  T. Suchi,et al.  Evaluation of serum neuron-specific enolase as a tumor marker for carcinoma of the lung. , 1983, Gan.

[14]  F. Suzuki,et al.  Immunoassay of three enolase isozymes in human serum and in blood cells. , 1983, Clinica chimica acta; international journal of clinical chemistry.

[15]  J. Minna,et al.  SERUM NEURON-SPECIFIC ENOLASE: A MARKER FOR DISEASE EXTENT AND RESPONSE TO THERAPY OF SMALL-CELL LUNG CANCER , 1982, The Lancet.

[16]  D. Ettinger,et al.  Multiple biologic markers in the monitoring of treatment for patients with small cell carcinoma of the lung: The use of serial levels of plasma cea and serum carbohydrates , 1981, Cancer.

[17]  J. Polak,et al.  NEURON-SPECIFIC ENOLASE IS PRODUCED BY NEUROENDOCRINE TUMOURS , 1981, The Lancet.

[18]  W. W. Daniel.  Applied Nonparametric Statistics , 1978 .

[19]  F. Goodwin,et al.  Brain endolases as specific markers of neuronal and glial cells. , 1978, Science.

[20]  F. Khan,et al.  DIABETOGENIC DRUGS , 1976, The Lancet.

[21]  K. Gerbitz,et al.  Enolase Isoenzymes as Tumour Markers , 1986, Journal of clinical chemistry and clinical biochemistry. Zeitschrift fur klinische Chemie und klinische Biochemie.

[22]  R. Holle,et al.  Prospective multicenter study of hormone markers in small cell lung cancer. , 1985, Recent results in cancer research. Fortschritte der Krebsforschung. Progres dans les recherches sur le cancer.

[23]  B. Milleron,et al.  Serum neuron-specific enolase. A marker for disease extent and response to therapy for small-cell lung cancer. , 1985, Chest.

[24]  N. Tryding,et al.  Recommended methods for the determination of four enzymes in blood. , 1974, Scandinavian journal of clinical and laboratory investigation.